These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30008083)

  • 1. Supraspinal interaction between HIV-1-gp120 and cannabinoid analgesic effectiveness.
    Palma J; Narasimhan M; Guindon J; Benamar K
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1157-1161. PubMed ID: 30008083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effects of cannabinoid receptor agonist WIN55,212-2 in the nucleus cuneiformis in animal models of acute and inflammatory pain in rats.
    Ebrahimzadeh M; Haghparast A
    Brain Res; 2011 Oct; 1420():19-28. PubMed ID: 21911208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
    Wilson-Poe AR; Lau BK; Vaughan CW
    Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.
    Wilson-Poe AR; Pocius E; Herschbach M; Morgan MM
    Pharmacol Biochem Behav; 2013 Jan; 103(3):444-9. PubMed ID: 23063785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.
    Pan JX; Wang ZL; Li N; Han ZL; Li XH; Tang HH; Wang P; Zheng T; Fang Q; Wang R
    Neurosci Lett; 2014 Aug; 578():187-91. PubMed ID: 25010019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
    Vaughan CW; Connor M; Bagley EE; Christie MJ
    Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.
    Guindon J; Desroches J; Dani M; Beaulieu P
    Eur J Pharmacol; 2007 Jul; 568(1-3):173-6. PubMed ID: 17555742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function.
    Sbarski B; Akirav I
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):955-969. PubMed ID: 30026011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.
    Hough LB; Svokos K; Nalwalk JW
    Brain Res; 2009 Jan; 1247():62-70. PubMed ID: 18983834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Postoperative Analgesic Exposure to the Cannabinoid Receptor Agonist WIN55 on Osteogenic Differentiation and Spinal Fusion in Rats.
    Yun C; Haleem MS; Jeong S; Oyer MA; Driscoll AJ; Chang KY; Yun J; Paul J; Lubbe RJ; Stock SR; Hsu WK; Hsu EL
    J Bone Joint Surg Am; 2021 Jun; 103(11):984-991. PubMed ID: 33759484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rodent amygdala contributes to the production of cannabinoid-induced antinociception.
    Manning BH; Martin WJ; Meng ID
    Neuroscience; 2003; 120(4):1157-70. PubMed ID: 12927220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.
    Hu S; Sheng WS; Rock RB
    PLoS One; 2013; 8(10):e77577. PubMed ID: 24147028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.
    Dableh LJ; Yashpal K; Henry JL
    Eur J Pharmacol; 2009 Jan; 602(1):36-40. PubMed ID: 19027734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
    Ulugol A; Topuz RD; Gunduz O; Kizilay G; Karadag HC
    Fundam Clin Pharmacol; 2016 Dec; 30(6):537-548. PubMed ID: 27371029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
    Hohmann AG; Tsou K; Walker JM
    J Neurophysiol; 1999 Feb; 81(2):575-83. PubMed ID: 10036261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.
    Fang Q; Han ZL; Li N; Wang ZL; He N; Wang R
    Neuropharmacology; 2012 Feb; 62(2):855-64. PubMed ID: 21945715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections.
    Martin WJ; Coffin PO; Attias E; Balinsky M; Tsou K; Walker JM
    Brain Res; 1999 Mar; 822(1-2):237-42. PubMed ID: 10082902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity.
    LaVigne JE; Hecksel R; Keresztes A; Streicher JM
    Sci Rep; 2021 Apr; 11(1):8232. PubMed ID: 33859287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception.
    Gutierrez T; Nackley AG; Neely MH; Freeman KG; Edwards GL; Hohmann AG
    Brain Res; 2003 Oct; 987(2):176-85. PubMed ID: 14499961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.